BioPharmSignal logoBioPharmSignal

Biotech News

Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study

Achieve Life Sciences (ACHV)Achieve Life SciencesCompany update

ACHV (ACHV) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is achv.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

ACHVAchieve Life Sciences2026-05-19 18:15 EST

Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment

ACHVAchieve Life Sciences2026-08-03 12:30 EST

Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality

WVEWave Life Sciences2026-01-12 12:30 EST

Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio

SLSSELLAS Life Sciences Group, Inc.2025-12-07 23:00 EST

SELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025

SLSSELLAS Life Sciences Group, Inc.2025-11-03 14:00 EST

SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American Society of Hematology (ASH) Annual Meeting

KZRKezar Life Sciences2019-11-08 21:13 EST

Kezar Life Sciences to Host Conference Call and Webcast during the American College of Rheumatology Annual Meeting to Discuss Updated Results with KZR-616

WVEWave Life Sciences2026-07-30 11:30 EST

Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

KZRKezar Life Sciences2020-05-28 20:01 EST

Kezar Life Sciences to Participate in Fireside Chat During the Jefferies Virtual Healthcare Conference

AZTAAzenta Life Sciences2026-04-07 12:15 EST

Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution

View all latest news

Achieve Life Sciences

Nicotine Dependence Company Achieve Life Sciences develops cytisinicline as a treatment for nicotine dependence and smoking cessation. Cytisinicline Cytisinicline is a plant-derived partial agonist of the nicotinic acetylcholine receptor and is intended as a shorter-course alternative to existing prescription therapies. Phase 3...

Recent company news

ACHVAchieve Life Sciences2026-08-11 12:30 EST

Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates

ACHVAchieve Life Sciences2026-08-03 12:30 EST

Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality

ACHVAchieve Life Sciences2026-07-31 12:30 EST

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

ACHVAchieve Life Sciences2026-06-29 12:30 EST

Achieve Life Sciences Joins Russell 2000® Index

ACHVAchieve Life Sciences2026-06-22 12:30 EST

Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

Stock data

Close
7.99 USD
Market cap
516.38M USD
Exchange
NASDAQ
Sector
Life Science Tools
Location
United States